BIT
SLXP

BlackRock Institutional Trust’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlackRock Institutional Trust’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,833,367
Closed -$317M – 4058
2015
Q1 		$317M Buy
1,833,367
+67,898
+4% +$9.97M 0.05% 387
2014
Q4 		$203M Buy
1,765,469
+45,490
+3% +$5.51M 0.03% 535
2014
Q3 		$269M Sell
1,719,979
-40,535
-2% -$5.88M 0.05% 402
2014
Q2 		$217M Sell
1,760,514
-122,859
-7% -$13.6M 0.04% 492
2014
Q1 		$195M Buy
1,883,373
+183,170
+11% +$18.8M 0.03% 523
2013
Q4 		$153M Buy
1,700,203
+92,649
+6% +$7.39M 0.03% 621
2013
Q3 		$108M Buy
1,607,554
+262,315
+19% +$18.1M 0.02% 749
2013
Q2 		$89M Buy
+1,345,239
New +$76.9M 0.02% 797

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust's SLXP Position: Q2 2015 in Review

BlackRock Institutional Trust sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,833,367 shares — an estimated $317M sold.

BlackRock Institutional Trust first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $317M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • BlackRock Institutional Trust reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 1,833,367 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $317M.
  • BlackRock Institutional Trust first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • BlackRock Institutional Trust's SALIX PHARMACEUTICALS LTD DEL position peaked at $317M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BlackRock Institutional Trust's 13F filing for Q2 2015, filed 7 Aug 2015.